Outcomes Following Neoadjuvant or Adjuvant Chemotherapy for cT2-4N0-1 Non-Small Cell Lung Cancer: A Propensity-Matched Analysis

OBJECTIVE: Comparative survival between neoadjuvant chemotherapy (NC) and adjuvant chemotherapy (AC) for patients with cT2-4N0-1M0 non-small cell lung cancer (NSCLC) has not been extensively studied. METHODS: Patients with cT2-4N0-1M0 NSCLC who received platinum-based chemotherapy were retrospective...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Cardiovasc Surg
Autori principali: Brandt, Whitney S., Yan, Wanpu, Zhou, Jian, Tan, Kay See, Montecalvo, Joseph, Park, Bernard J., Adusumilli, Prasad S., Huang, James, Bott, Matthew J., Rusch, Valerie W., Molena, Daniela, Travis, William D., Kris, Mark G., Chaft, Jamie E., Jones, David R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344258/
https://ncbi.nlm.nih.gov/pubmed/30415902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.09.098
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi